FDA Authorizes Light Therapy for Dry AMD
Abstract
Imagine a special light that could protect vision in people with dry age-related macular degeneration (dry AMD) without eye injections. That’s what a new treatment aims to do.
Dry AMD affects mostly adults over 55, and it’s a leading cause of vision loss. Right now, only specific types of dry AMD can be treated — and the treatment involves eye injections that may slow the disease without improving vision. Some patients with dry AMD may also benefit from special vitamins.
The new light therapy — called photobiomodulation — could be a big breakthrough. It’s the first non-invasive treatment authorized by the FDA for use in treating dry AMD, which means no needles are needed.
Read more on aao.org or download the PDF»
